| GLOIX | OSMCX | GLOIX / OSMCX | |
| Total Expense Ratio | 0.92 | 2.13 | 43% |
| Annual Report Gross Expense Ratio | 4.10 | 2.13 | 192% |
| Fund Existence | 18 years | 28 years | - |
| Gain YTD | 33.590 | 15.981 | 210% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 1000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 6.43M | 2.73B | 0% |
| Annual Yield % from dividends | 0.53 | 0.48 | 112% |
| Returns for 1 year | 28.19 | 0.82 | 3,423% |
| Returns for 3 years | 38.95 | 2.40 | 1,621% |
| Returns for 5 years | 13.24 | -27.38 | -48% |
| Returns for 10 years | -27.07 | 7.46 | -363% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SVXFX | 74.21 | 0.58 | +0.79% |
| Smead International Value I1 | |||
| WSTYX | 83.25 | 0.14 | +0.17% |
| Macquarie Science and Technology Y | |||
| AWSSX | 18.36 | N/A | N/A |
| Invesco Global Core Equity R6 | |||
| CSMIX | 45.80 | -0.01 | -0.02% |
| Columbia Small Cap Value Discv A | |||
| CLTCX | 16.37 | -0.07 | -0.43% |
| Catalyst/Lyons Tactical Allocation C | |||